Zoledronic acid: an unending tale for an antiresorptive agent.
about
Nanoparticles for the delivery of zoledronic acid to prostate cancer cells: a comparative analysis through time lapse video-microscopy technique.Combined HMG-COA reductase and prenylation inhibition in treatment of CCM.Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers.Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acidInhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid.Codelivery of zoledronic acid and doublestranded RNA from core-shell nanoparticles.Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid.Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells.Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumorsEmerging pathways as individualized therapeutic target of multiple myeloma.The Electroporation as a Tool for Studying the Role of Plasma Membrane in the Mechanism of Cytotoxicity of Bisphosphonates and Menadione.Zoledronic acid induces apoptosis and autophagy in cervical cancer cells.Differential effects of ibandronate, docetaxel and farnesol treatment alone and in combination on the growth of prostate cancer cell lines.Self-assembling nanoparticles encapsulating zoledronic acid inhibit mesenchymal stromal cells differentiation, migration and secretion of proangiogenic factors and their interactions with prostate cancer cells.Anti-angiogenic and anti-tumor effects of metronomic use of novel liposomal zoledronic acid depletes tumor-associated macrophages in triple negative breast cancer.Models for anti-tumor activity of bisphosphonates using refined topochemical descriptors.
P2860
Q27302083-145C4FBC-76B7-4B77-A154-F96040608A26Q33737847-F6172FB0-26C8-42EE-9E32-D0E76BBC40BCQ34025648-151EE846-EA0D-4048-8E0B-754EC5804221Q34786475-F566634C-E830-4F11-A03A-D81F45EC7B91Q36459367-AA230561-FE8E-48B4-A593-82980AECCA81Q36520822-87934C90-345A-4A29-BD56-205AF7A6EB02Q36524247-73147CF6-97D5-4BDC-93D6-C5BA7E3E0474Q36544608-B67566C2-7E12-4DA7-83F6-274B0B2CE830Q37190433-2FC1E69A-2B8E-45B7-950E-24127467A98CQ38112176-2C0C364B-B69D-4239-A32A-C45EEED9DC03Q38780783-D4F58EE2-8785-4B3F-BB51-382B5C6073E5Q38964271-FAB706F3-D4D7-49D3-992A-D1DC46EB1791Q39709311-F52EE09C-BEFB-4CEA-B962-D8229A6A1519Q42335714-4BE5EFD2-9E79-440C-ACDE-E041E3A17078Q47101676-F7E0599B-42E4-485E-9CCE-99A99DB408E5Q53743085-E1B8CBA9-9D7E-4BC2-8782-179E29842F6E
P2860
Zoledronic acid: an unending tale for an antiresorptive agent.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Zoledronic acid: an unending tale for an antiresorptive agent.
@en
Zoledronic acid: an unending tale for an antiresorptive agent.
@nl
type
label
Zoledronic acid: an unending tale for an antiresorptive agent.
@en
Zoledronic acid: an unending tale for an antiresorptive agent.
@nl
prefLabel
Zoledronic acid: an unending tale for an antiresorptive agent.
@en
Zoledronic acid: an unending tale for an antiresorptive agent.
@nl
P2093
P2860
P1476
Zoledronic acid: an unending tale for an antiresorptive agent.
@en
P2093
Alberto Abbruzzese
Michele Caraglia
Monica Marra
Raffaele Addeo
Silvio Naviglio
P2860
P304
P356
10.1517/14656560903485664
P407
P577
2010-01-01T00:00:00Z